Dianthus Therapeutics (Dianthus Therapeutics) Beginning Cash Position : $132.39 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Dianthus Therapeutics Beginning Cash Position?

Dianthus Therapeutics's Beginning Cash Position for the quarter that ended in Mar. 2024 was $132.39 Mil.

Dianthus Therapeutics's quarterly Beginning Cash Position increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($152.48 Mil) but then declined from Dec. 2023 ($152.48 Mil) to Mar. 2024 ($132.39 Mil).

Dianthus Therapeutics's annual Beginning Cash Position increased from Dec. 2021 ($2.66 Mil) to Dec. 2022 ($7.64 Mil) and increased from Dec. 2022 ($7.64 Mil) to Dec. 2023 ($15.43 Mil).

Dianthus Therapeutics Beginning Cash Position Historical Data

The historical data trend for Dianthus Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dianthus Therapeutics Beginning Cash Position Chart

Dianthus Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Beginning Cash Position

2.66

7.64

15.43

Dianthus Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial			36.94	15.43	-	152.48	132.39

Dianthus Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Dianthus Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Dianthus Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Dianthus Therapeutics (Dianthus Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dianthus Therapeutics Inc (NAS:DNTH) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

87E:Germany

Address

7 Times Square, 43rd Floor, New York, NY, USA, 10036

Website

https://www.dianthustx.com

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is comprised of an experienced team of biotech and pharma executives who are leading the next generation of antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune diseases.

Dianthus Therapeutics (Dianthus Therapeutics) Headlines

From GuruFocus

Insider Buying: Fairmount Funds Management LLC Acquires 24,254 Shares of Dianthus Therapeutics Inc

By GuruFocus Research • 09-14-2023

Fairmount Funds Management LLC Acquires New Stake in Dianthus Therapeutics Inc

By GuruFocus Research • 09-29-2023